다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Kymera Therapeutics Inc (KYMR)
Kymera Therapeutics Inc (KYMR) 뉴스

KYMR

Kymera Therapeutics (KYMR)

Kymera Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:KYMR

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/08/28	20:00	GlobeNewswire Inc.	Kymera Therapeutics to Participate in Upcoming September Investor Conferences	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/08/22	00:15	GlobeNewswire Inc.	Kymera Therapeutics Announces Closing of Upsized $225 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/08/21	06:24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/08/21	05:31	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/08/20	11:45	GlobeNewswire Inc.	Kymera Therapeutics Announces Pricing of $225 Million Public Offering	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/08/20	05:01	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/08/20	05:01	GlobeNewswire Inc.	Kymera Therapeutics Announces Proposed Public Offering	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/08/07	20:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/08/07	20:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/08/07	20:00	GlobeNewswire Inc.	Kymera Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/07/31	20:00	GlobeNewswire Inc.	Kymera Therapeutics to Report Second Quarter 2024 Financial Results on August 7	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/07/17	07:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/07/17	05:28	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/07/16	05:31	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/07/09	20:00	GlobeNewswire Inc.	Kymera Therapeutics to Present in Fireside Chat at the UBS Virtual Targeted Protein Degradation Day	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/07/09	19:54	IH Market News	BP Slashes Profit Forecast by $700 Million; Morgan Stanley Predicts S&P 500 10% Drop, and More News	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/07/09	05:22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/07/09	05:05	GlobeNewswire Inc.	Kymera Announces Expansion of KT-474 (SAR444656) HS and AD Phase 2 Studies Following Interim Review of Safety and Efficacy	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/06/20	21:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/06/14	20:00	GlobeNewswire Inc.	Kymera Therapeutics Presents New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/06/01	21:00	GlobeNewswire Inc.	Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/05/29	20:00	GlobeNewswire Inc.	Kymera Therapeutics to Participate in Upcoming June Investor Conferences	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/05/24	06:00	GlobeNewswire Inc.	Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/05/23	00:20	GlobeNewswire Inc.	Kymera Therapeutics Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader at the ATS Annual Meeting	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/05/14	23:00	GlobeNewswire Inc.	Kymera Therapeutics to Present New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/05/08	20:00	GlobeNewswire Inc.	Kymera Therapeutics to Participate in Upcoming May Investor Conferences	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/05/02	20:00	GlobeNewswire Inc.	Kymera Therapeutics Announces First Quarter 2024 Financial Results and Provides a Business Update	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/04/25	20:00	GlobeNewswire Inc.	Kymera Therapeutics to Report First Quarter 2024 Financial Results on May 2	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/04/08	20:00	GlobeNewswire Inc.	Kymera Therapeutics Announces Scientific Presentations at the American Association for Cancer Research 2024 Annual Meeting	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/03/09	00:00	GlobeNewswire Inc.	Kymera Therapeutics Presents Preclinical Data for STAT6 and TYK2 First-In-Class, Oral Degrader Immunology Programs at the American Academy of Dermatology Annual Meeting	NASDAQ:KYMR	Kymera Therapeutics Inc

검색 관련기사 보기:NASDAQ:KYMR

1 2 3 4 5 6 7 8 9 10 다음 >>

Deutsche Telekom (QX)

BNP Paribas (QX)

JP Morgan Chase

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관